NCT06007547 - Prophylactic Minimally Invasive Surfactant Evaluation | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2027

Conditions

Respiratory Distress Syndrome, NewbornPremature Birth

Interventions

DRUG

Poractant Alfa

Poractant alfa (Curosurf) 200mg/kg administered under direct laryngoscopy using a surfactant instillation catheter

Trial Locations (1)

RECRUITING

Northshore University Healthsystem, Evanston